In an effort to find ways to improve long-term outcomes for people with opioid use disorder, University of Massachusetts Amherst epidemiology researcher Elizabeth Evans set out to study the obstacles to treating this chronic condition with an effective medication, buprenorphine-naloxone.

Source link